Goh Han-seung, President of Samsung Bioepis, Appointed as the 7th President of the Bio Association

2-Year Term

Go Han-seung, Chairman of the Korea Bio Association (Photo by Korea Bio Association)

[Asia Economy Reporter Kim Ji-hee] Koh Han-seung, President of Samsung Bioepis, has been inaugurated as the 7th President of the Korea Bio Association.

The Korea Bio Association announced on the 28th that Koh Han-seung was elected as the 7th president of the association at the '2021 Annual General Meeting' held on the 27th. The association president is elected by the participation of more than half of the voting regular members and the approval of more than half of the attending regular members. President Koh was elected with the unanimous approval of all participating regular members. He will represent the Korea Bio Association for the next two years.

President Koh said, "I feel a heavy responsibility as I take on this important role amid the difficult situation of the domestic bio industry due to COVID-19," adding, "I will actively communicate with the domestic bio industry in line with the trends of the times and through networking, ensure that K-Bio plays a leading role on the global stage."

He previously served as head of the Bio & Health team at Samsung Advanced Institute of Technology and executive director of the New Business Team at Samsung Strategy and Planning Office. From 2012, he served as vice president at Samsung Bioepis until 2015, and has been serving as president since then.

Meanwhile, Lim Jong-yoon, President of Hanmi Pharmaceutical, will continue his term as chairman of the association. All executives, including 18 vice presidents, 16 directors, and 2 auditors, will also continue their terms.

This content was produced with the assistance of AI translation services.